Why Choose SurSight®?

Amniotic membrane sheets have a long clinical history in a variety of applications. SurSight® is specifically designed to be smooth and clear for ophthalmic applications. SurSight® is minimally manipulated to retain the natural properties of the amniotic membrane, and provides clinicians with a flexible sheet that can be used in a variety of applications with ease.

SurSight® is processed into a variety of circular sizes that are tailored for use in ophthalmology. It is minimally manipulated to preserve the natural benefits of the amniotic tissue.

Surgenex SurSight
Surgenex SurSight

What Is SurSight®?

SurSight® is a dehydrated, minimally manipulated, amniotic membrane allograft for homologous use. It is shelf stable and provided in multiple sizes to provide maximum flexibility for a variety of clinical applications.

SurSight® has been specifically processed to generate a smooth, transparent finish ideal for ophthalmic applications. Our proprietary processing methods yield an irradiated product that is shelf stable and safe for use.

Key features

  • Rigorous quality and serological testing exceeding FDA requirements
  • Single layer amnion to provide a smooth and transparent finish
  • Variety of sizes tailored to accommodate ophthalmic use

AMs Can Be Used to Treat a Variety of Eye Conditions

A unique thing about amniotic membranes is how broadly they can be used, allowing you to customize the ways in which you use them to the focuses of your practice. Here are just a few of the conditions that AMs have been used effectively to treat in the past:

  • Bullous keratopathy
  • Chemical or physical burns to the eye
  • Conjunctival reconstruction
  • Corneal degeneration
  • Corneal ulcers/Neurotrophic keratitis
  • Dystrophy
  • Epithelial abrasions, defects, and erosion
  • Limbal stem cell deficiency
  • Neurotropic ulcers
  • Post-keratoplasty
  • Ptergium
  • Severe dry eye
  • Stevens-Johnson syndrome/Lyell’s syndrome
  • Stromal ulcerations

A Superior Solution for Eye Injury Treatment

Amniotic Membranes are collected from the innermost layer of the placenta, and are procured from a strictly-vetted, single donor following a pre-scheduled C-section procedure. This means the the membranes you place on the eye have histocompatibility antigens and are universally tolerated, making for a faster and more comfortable treatment with fewer risks.

These membranes have anti-flammatory and anti-scarring properties and promote epithelial growth, meaning that they don’t just act as bandages – they promote healing.

Product Sizes

SurSight® is optimized for clarity and specifically designed to meet the needs of our providers. SURGENEX® provides multiple sizes to provide maximum flexibility for a variety of clinical applications.

Surgenex SurSight


Surgenex is proud to be compliant with all FDA mandated current Good Tissue Practices, accredited by the American Association of Tissue Banks, and licensed with the States of California, Delaware, Illinois, New York, Oregon, Florida, and Maryland.

Minimal Manipulation

Our process extracts the membrane from the placental tissue, leaving a single amniotic membrane layer which is then dehydrated and irradiated. SurSight®‘s minimally manipulated process retains the benefits of the amniotic membrane providing clinicians with a smooth and transparent allograft ideal for ophthalmic applications.

Serological Testing

SurSight® is thoroughly tested for safety and efficacy. We pride ourselves on our tightly controlled quality processes that exceed regulatory safety requirements.